# Jaivir Pall

> Jaivir Pall is a seed investor at Harbr (London) backing Wellness and Health Care. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Harbr](https://shizune.co/investors/profile/harbr-aa18)
- Location: London, United Kingdom
- Total investments: 1
- Last investment: Jun 2025
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/jaivir-pall-09224a33

Jaivir Pall is a seed investor at Harbr in London focused on Wellness and Health Care. Jaivir Pall is the Board of Directors of Abvance Therapeutics. With a background in investment banking, finance, business development, and data science, Jai is a multi-disciplinary commercial leader. He assists startups in improving their commercial and financial models as well as preparing for investment. Jai lives with type 1 diabetes who alsohappens to be an expert in the subject. He consults with startups, corporations, and regulators on diabetes-related research and technology on a regular basis. He was instrumental in the establishment of Pathfinder Health in India, working alongside Dr Niti Pall. After that, he worked for KPMG in India before moving to the UK and becoming the commercial lead for Practice Unbound, a company that was extremely successful in providing services to NHS England and Wales.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Wellness | 1 | 100% |
| Health Care | 1 | 100% |
| Therapeutics | 1 | 100% |
| Personal Health | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Abvance Therapeutics | Abvance Therapeutics is a biotechnology research company that focuses on innovative solutions to address unmet needs in diabetes care. The company is known for developing a novel coformulation of insulin and glucagon, which could revolutionize diabetes care. This treatment combines two well-understood and FDA-approved peptides to control glycemiawhile mitigating the threat of hypoglycemia. The company's team of scientists and physicians have discovered this unique approach to diabetes treatment, aiming to reduce hypoglycemia and improve patient outcomes. |  | Seed | Jun 24, 2025 |  |

1 of 1 investments shown.

## About Harbr

VC Fund · London, United Kingdom

Harbr is an accelerator and venture builder for health technology businesses.

2 contacts available at Harbr.

| Name | Title | Profile |
| --- | --- | --- |
| Jaivir Pall | Founder & Partner | https://shizune.co/investors/profile/jaivir-pall |
| Omar Daniel | Co-founder & Partner | https://shizune.co/investors/profile/omar-daniel |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Jaivir Pall invest in?

Jaivir Pall invests primarily in Wellness, Health Care and Therapeutics startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Jaivir Pall last invest?

The most recent investment recorded for Jaivir Pall closed in Jun 2025. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co